Cell and Gene Therapy Insights Volume 12 Issue 5

CELL AND GENE THERAPY INSIGHTS

Volume 12 Issue 5

Cell and Gene Therapy Insights Volume 12 Issue 5

Download PDF

Featuring

Issue Spotlight: Non-viral delivery: making a real-world impact
Supply Chain focus: Cyropreservation & cold chain
Translational Research & Clinical Development focus: Cell Therapy R&D & translation
Other articles
Webinar

Non-viral delivery: making a real-world impact

Commentary

Don’t shoot the messenger: non‑viral delivery’s real‑world revolution

Don’t shoot the messenger: non‑viral delivery’s real‑world revolution

Ryan T Coones , Denis Besic

Viewpoint

The non-viral delivery era has begun, with challenges ahead

The non-viral delivery era has begun, with challenges ahead

Yu Cao, Pete Smith

Interview

Beyond viral vectors: Hao Wu on non-viral delivery, immune-evasive DNA, and what the field still needs to prove

Beyond viral vectors: Hao Wu on non-viral delivery, immune-evasive DNA, and what the field still needs to prove

Cyropreservation & cold chain

Infographic

5 ways packaging impacts cell therapy outcomes

5 ways packaging impacts cell therapy outcomes

Interview

Frozen in time: rethinking cryopreservation as a core process parameter in cell and gene therapy

Frozen in time: rethinking cryopreservation as a core process parameter in cell and gene therapy

Cell Therapy R&D & translation

Expert Insight

A consortium‑driven framework for expanding access to interventional neurosurgical cell therapy for Parkinson's disease

A consortium‑driven framework for expanding access to interventional neurosurgical cell therapy for Parkinson's disease

Howard J Federoff, Valeria Yartseva

Interview

The regulatory frontier advancing cell and gene therapy policy in Singapore and beyond

The regulatory frontier advancing cell and gene therapy policy in Singapore and beyond

Eddie Tan Han Pin

Event Preview

Event preview of the 6th iPSC Drug Development Summit

Event preview of the 6th iPSC Drug Development Summit

Abigail Pinchbeck

articles

Editorial

Editor’s picks: the future of CAR-T cell therapy

Editor’s picks: the future of CAR-T cell therapy

Abigail Pinchbeck

Innovator Insight

Engineering armored CAR‑T cells to overcome the solid tumor microenvironment

Engineering armored CAR‑T cells to overcome the solid tumor microenvironment

Developing streamlined, flexible cell therapy process workflows: from upstream to formulation and fill‑finish operations

Developing streamlined, flexible cell therapy process workflows: from upstream to formulation and fill‑finish operations

Namritha Ravinder, Carl Dargitz

Infographic

Rapid sterility & mycoplasma testing in cell therapy

Rapid sterility & mycoplasma testing in cell therapy

Podcast

From one target to many: how high‑plex ddPCR technology is changing CGT from development to analytics

From one target to many: how high‑plex ddPCR technology is changing CGT from development to analytics

Christian Overgaard

Interview

From shelved to delivered: CGTxchange and the push for improved patient access to cell and gene therapies

From shelved to delivered: CGTxchange and the push for improved patient access to cell and gene therapies

Event Summary

UK Biotech Day 2026 post-event reflections: key industry takeaways

UK Biotech Day 2026 post-event reflections: key industry takeaways

Fabio D'Agostino

Event Summary: ASGCT 2026 Annual Meeting

Event Summary: ASGCT 2026 Annual Meeting

Abigail Pinchbeck

ASGCT 2026: Editor’s takeaways from the annual meeting

ASGCT 2026: Editor’s takeaways from the annual meeting

Abigail Pinchbeck

Turning biological variability into consistent outcomes with cell culture vessels

Turning biological variability into consistent outcomes with cell culture vessels

Paulina Zatarain